Precision Medicine in Oncology

The AJMC® Precision Medicine in Oncology compendium is a comprehensive resource for clinical news and expert insights for molecular profiling of tumors.

Latest News

COTA’s Miruna Sasu on Real-world Evidence: “The Ecosystem Has Changed”
COTA’s Miruna Sasu on Real-world Evidence: “The Ecosystem Has Changed”

June 23rd 2022

Miruna Sasu, PhD, MBA, became president and CEO of COTA Healthcare in March 2022, not quite a year after joining the company as its chief strategy officer. As the importance of RWD grows, Sasu is ready to take its use in precision oncology to new levels. She spoke with Evidence-Based Oncology™ (EBO) about her new role.

FDA Accepts Futibatinib for Priority Review for FGFR2 Rearrangements and Fusions in Cholangiocarcinoma
FDA Accepts Futibatinib for Priority Review for FGFR2 Rearrangements and Fusions in Cholangiocarcinoma

March 30th 2022

Further Analysis Needed to Incorporate Liquid Biopsy in the Community Setting
Further Analysis Needed to Incorporate Liquid Biopsy in the Community Setting

February 23rd 2022

Interferon-α Therapy Bests Donor Lymphocyte Infusion in AML Comparison Study
Interferon-α Therapy Bests Donor Lymphocyte Infusion in AML Comparison Study

February 18th 2022

Improvement Needed for Liquid Biopsy to Have Clinical Utility in Lung Cancer
Improvement Needed for Liquid Biopsy to Have Clinical Utility in Lung Cancer

February 15th 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.